PHAT
Phathom Pharmaceuticals, Inc. · Healthcare
Pres, Chief Exec Terrie Curran sold $48K of Phathom Pharmaceuticals, Inc.
Sold$47,729
$8.20Price
5,821Shares
−3%Stake
What PHAT did after the filing
- The stock from Fri, Jan 20 close, $8.61
- +0.7%
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Mar 6 close.
Traded Fri, Jan 20. Filed Fri, Jan 20, 2:39 PM ET, during the session. Returns use the Jan 20 close and the Mar 6 close. Not investment advice.